CBD is not a scam in the sense that it’s a real compound with at least one proven medical use. The FDA has approved a purified CBD medication for treating seizures in rare forms of epilepsy. But the vast majority of CBD products sold online and in stores occupy a murky space: loosely regulated, frequently mislabeled, and marketed with health claims that outrun the evidence. The honest answer is that CBD itself has real biological activity, but the commercial CBD market has serious problems that make it easy to waste your money or get a product that doesn’t contain what it says on the label.
What CBD Can Actually Do
The strongest evidence for CBD is in epilepsy. The FDA approved a purified CBD drug called Epidiolex for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients one year of age and older. This approval came through rigorous clinical trials with thousands of patients, and it remains the only FDA-approved CBD product on the market.
Beyond epilepsy, the most commonly cited use is anxiety. A 2024 randomized clinical trial of 178 participants found that a pharmaceutical-grade CBD oral solution significantly reduced anxiety scores compared to placebo, with improvements across multiple anxiety and sleep measures. That’s promising, but it used a precisely formulated product at a controlled dose, which is very different from grabbing a bottle of CBD gummies off a shelf. For chronic pain, the picture is even murkier. Most pain studies have been small, short-term, or used CBD in combination with THC, making it hard to isolate CBD’s contribution.
So CBD has legitimate pharmacological effects. It’s not snake oil. But “CBD does something real” and “the CBD product you’re buying will help you” are two very different statements.
The Labeling Problem
A Johns Hopkins study tested 105 over-the-counter CBD products and found that only 24% were accurately labeled. Eighteen percent contained less CBD than advertised, and 58% contained more. Fifteen percent of the products didn’t even list the total milligrams of CBD on the label at all. THC turned up in 35% of products tested, including four that were specifically labeled “THC free.”
This means you often don’t know what you’re actually taking. If a product contains significantly less CBD than it claims, any effect you feel could easily be placebo. If it contains undisclosed THC, you could fail a drug test or experience psychoactive effects you weren’t expecting. The lack of consistent labeling makes it nearly impossible to replicate a dose that worked for you, since the next bottle from the same brand might contain a different amount.
Contamination Is Common
Because CBD products aren’t regulated like pharmaceuticals, quality control varies wildly. A study testing 121 edible CBD products found lead in 42%, mercury in 37%, arsenic in 28%, and cadmium in 8%. Four products exceeded California’s safety threshold for daily lead consumption in just two servings. Phthalates, a group of industrial chemicals linked to hormonal disruption, were detected in 13% to 80% of products depending on the specific compound tested.
These aren’t typically at acutely dangerous levels, but the contamination is described as “pervasive.” If you’re taking CBD daily for months or years, low-level exposure to heavy metals adds up.
Your Body Absorbs Very Little of It
One of the least-discussed problems with CBD products is bioavailability. When you swallow a CBD gummy or capsule, your body absorbs a small fraction of what’s in it. One estimate puts oral bioavailability at roughly 6% when CBD is taken with food. Even under favorable conditions, only about a third of the CBD you swallow makes it to your intestinal fluid where absorption can happen. The rest is broken down by your liver and digestive system before it ever reaches your bloodstream.
This matters because the doses people typically use are already low. A national survey of fibromyalgia patients using CBD found they averaged about 16 mg per session and under 50 mg per day. At 6% bioavailability, a 25 mg gummy delivers roughly 1.5 mg of active CBD into your system. Clinical trials that show clear results tend to use pharmaceutical-grade formulations designed to maximize absorption, at doses that are often much higher than what most consumers take.
CBD Can Interact With Medications
CBD affects liver enzymes that your body uses to process many common drugs. Specifically, it inhibits two enzyme pathways responsible for metabolizing statins, certain antidepressants, and anti-seizure medications. When those enzymes are suppressed, the other drugs can build up to higher-than-intended levels in your blood, increasing the risk of side effects.
An FDA-led trial found that even consumer-level doses of daily CBD can elevate liver enzymes, a marker of liver stress. This is particularly concerning because many people who try CBD are already taking prescription medications for the same conditions they’re hoping CBD will treat, like anxiety or chronic pain. The combination can be more risky than either substance alone.
Why the Market Looks the Way It Does
The core issue is regulatory. The FDA has not approved CBD as a dietary supplement or food additive. No over-the-counter CBD product has gone through the approval process that would require proof of safety, accurate labeling, and manufacturing standards. Companies sell CBD products in a legal gray area, and the FDA has limited resources to enforce against thousands of brands simultaneously.
This creates a market where honest companies and dishonest ones sit side by side, and consumers have no reliable way to tell the difference. Some brands voluntarily submit to third-party testing and publish certificates of analysis. That’s better than nothing, but it’s still self-policing. There’s no mandatory standard, no required testing, and no consequences for a product that doesn’t contain what it claims.
The Bottom Line on Value
CBD is a real compound with documented effects on seizure disorders and suggestive evidence for anxiety. It’s not a fabricated substance and it’s not inherently fraudulent. But the commercial CBD market has characteristics that overlap significantly with scams: unverified health claims, products that don’t contain what they say, no regulatory oversight, and prices that don’t reflect what you’re actually getting.
If you’re considering CBD, the most important thing to understand is the gap between pharmaceutical-grade CBD used in clinical research and the bottle on the shelf at your local gas station or wellness shop. They share a name, but they don’t share quality standards, dosing precision, or evidence of effectiveness. A product that costs $40 and delivers an unknown amount of CBD with 6% absorption and possible heavy metal contamination is a very different proposition from a controlled medication that passed FDA review.